NORWALK, Conn., Oct. 17, 2014 /PRNewswire/ -- UBM Medica US announces that Neurology Times, a leading online community and information resource for neurologists and other healthcare providers, features special coverage on Parkinson disease and Alzheimer disease, with discussions of the latest developments in approaches to diagnosis.
Up to 1 million Americans have Parkinson disease, more than the total of those who have multiple sclerosis, muscular dystrophy, or Lou Gehrig disease. Diagnosis can be difficult because there are no confirmatory medical tests. More than 5 million Americans have Alzheimer disease, the 6th leading cause of death in the United States, and the number is expected to escalate in the coming years.
Recent coverage of these troubling disorders on Neurology Times includes the following:
- Tests for Autoantibodies in Brain Disease Raise Questions: There is increasing recognition of the role of anti-brain-specific autoantibodies in human disease. Serum testing for NMDAR and other autoantibodies is fraught with pitfalls, and careful clinical consideration is important.
- Use a Saliva Test to ID Neurodegenerative Disease?: Why ask patients to "spit in a cup"? Statistically significant protein differences have been found in Alzheimer disease saliva, and trends have been observed for Parkinson disease. Saliva could be used in a clinical test for neurodegenerative disease.
- Migraine and Parkinson Disease: New Study Finds a Link: In this podcast, lead author Ann Scher, PhD, gives a succinct overview of the details and what the findings may suggest.
About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach -- online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Online communities include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Americas which, through a range of aligned interactive environments, both physical and digital – increases business effectiveness for both customers and audiences through meaningful experiences, knowledge and connections. Headquartered in New York, UBM Americas brings together UBM's healthcare business, UBM Medica US; UBM Tech's technology communities, live events and custom services; UBM Canon's advanced design and manufacturing event, online and print brands; UBM Connect New York's catering, cruise shipping, contact-center management, and fine, specialty and custom chemical communities; and UBM Mexico's concrete, construction and hospitality services shows. For more information, visit www.UBMMedicaUS.com.
About UBM plc
UBM plc is a global events-led marketing services and communications company. We help businesses do business, bringing the world's buyers and sellers together at events and online, as well as producing and distributing news and specialist content. Our 5,500 staff in more than 30 countries are organized into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.
For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.
Jason J. Golden
Content Marketing Manager
SOURCE UBM Medica US